StockData
ABVC BioPharma, Inc. logo

ABVC BioPharma, Inc. (ABVC) stock

ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$0.91−0.03 (-3.15%)

Close on Nov 18, 2026Market cap $24.27MP/E –Yield –

ABVC BioPharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

ABVC BioPharma's price to sales ratio was 49.7× on Apr 30, 2025, against 65.1× a year earlier. Over the last 4 years it ranged from 4.5× to 334.9×, with a median of 80.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 202549.7×+35.0
2024Dec 31, 202414.7×+7.1
2023Dec 29, 20237.6×−145.7
2022Jan 31, 2022153.2×−54.6
2021Dec 31, 2021207.8×+8.1
2020Dec 31, 2020199.7×–

More ABVC BioPharma figures

See a number that looks wrong?